Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    YXT.com

    MCap

    USD127m

    Last close

    USD23.43

    ▲ 20.23 (632.19%)

    Northern Data Group

    MCap

    EUR486m

    Last close

    EUR7.56

    ▲ 2.33 (44.59%)

    Bodycote

    MCap

    GBP1,572m

    Last close

    GBP9.14

    ▲ −9.00 (−0.98%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Mendus – equity proposition

Mendus – equity proposition

Mendus — 11 videos in collection

More on this equity

Mendus (OMX: IMMU) is a clinical-stage immuno-oncology company based in Sweden and the Netherlands. It is focused on developing active immunotherapies to improve long-term survival in cancers, including blood-borne tumours, that are underserved by current immunotherapies, such as immune checkpoint inhibitors. The company’s lead clinical programme, vididencel, is an off-the-shelf cellular immunotherapy that is being developed as a maintenance therapy for acute myeloid leukaemia (AML).

There are five key reasons why Mendus may be considered an attractive investment opportunity.

  1. The clinical data for vididencel in AML to date has been very encouraging.
  2. Vididencel is an off-the-shelf therapy.
  3. A key differentiating characteristic of Mendus is its manufacturing capabilities.
  4. The company has multiple upcoming inflection points.
  5. Mendus has a broad offering, mitigating its exposure to binary risk events.

If you would like to find out more about Mendus, please see our website.

< Previous
Next >

You may also be interested in these:

Healthcare

Mendus – equity proposition

Healthcare

Mendus – executive interview
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.